PC3 In Vitro High Content Screening (HCS) Assay

CAT#: ITS-1022-YF1881
Target Cell Organism: Human
Target Cell Alternative Name: PC-3
Target Cell Name: PC3
Assay Type: High-throughput Screening, High Content Screening and Reporter Gene Assays
Assay Overview
This assay is to provide PC3-based In Vitro High Content Screening (HCS) Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
PC3
Target Cell Organism
Human
Target Cell Background
PC3 (PC-3) is a human prostate cancer cell line used in prostate cancer research and drug development. PC3 cells are useful in investigating biochemical changes in advanced prostate cancer cells and in assessing their response to chemotherapeutic agents. PC3 cells are also used to study viral infection in mammalian cells that exhibit an immune response.
Target Cell Alternative Name
PC-3
Related Diseases
Prostate Cancer
Research Area
Oncology
Assay Name
In Vitro High Content Screening (HCS) Assay
Short Description
PC3-cell based In Vitro High Content Screening (HCS) Assay
Assay Description
HCS is one of the latest techniques used in cancer drug discovery programs. Unlike traditional HTS platforms, HCS provides more visual information about the experiment being conducted. HCS is a very powerful tool for multivariate and quantitative data analysis. Cellbased HCS systems have also gained much attention in biological research and cancer drug discovery programs.
Assay Type
High-throughput Screening, High Content Screening and Reporter Gene Assays
For Research Use Only | Not For Clinical Use
Online Inquiry